Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.33 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.33 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.33 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | STAT6 | P42226 | 1/20 | 0.33 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.33 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.33 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.33 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.33 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.33 |
| ▸ | SLC47A1 | Q96FL8 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adamantane SCHEMBL6494384 | 0.94 | CYP2C9 (0.40) | CYP2C9LMNASLC22A2SLC22A1GRIN2D | |
| Adamantane SCHEMBL29707714 | 0.93 | CYP2C9 (0.46) | CYP2C9LMNASLC22A2SLC22A1GRIN2D | |
| Adamantane SCHEMBL1527414 | 0.93 | CYP2C9 (0.46) | CYP2C9LMNASLC22A2SLC22A1GRIN2D | |
| Adamantane SCHEMBL12761 | 0.93 | CYP2C9 (0.46) | CYP2C9LMNASLC22A2SLC22A1GRIN2D | |
| Adamantane SCHEMBL9016497 | 0.93 | CYP2C9 (0.46) | CYP2C9LMNASLC22A2SLC22A1GRIN2D | |
| Adamantane SCHEMBL25252048 | 0.86 | CYP2C9 (0.43) | CYP2C9LMNASLC22A2SLC22A1GRIN2D | |
| Adamantane SCHEMBL21820021 | 0.86 | CYP2C9 (0.43) | CYP2C9LMNASLC22A2SLC22A1GRIN2D | |
| Adamantane SCHEMBL21067465 | 0.86 | CYP2C9 (0.43) | CYP2C9LMNASLC22A2SLC22A1GRIN2D | |
| Adamantane SCHEMBL21192802 | 0.86 | CYP2C9 (0.43) | CYP2C9LMNASLC22A2SLC22A1GRIN2D | |
| Adamantane SCHEMBL20741994 | 0.86 | CYP2C9 (0.43) | CYP2C9LMNASLC22A2SLC22A1GRIN2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115996826-A | Cutting blade with concave bevel and hair removal device | GFD钻石制品有限公司 | 2023-04-21 | — | — | CN | claimed |
| CN-115768608-A | Cutting blade and hair removing device | GFD钻石制品有限公司 | 2023-03-07 | — | — | CN | claimed |
| CN-115715250-A | Shaving device | 吉列有限责任公司 | 2023-02-24 | — | — | CN | claimed |
| US-20050253502-A1 | Optically enhanced nanomaterials | MATSUSHITA ELECTRIC WORKS, LTD. (JP) | 2005-11-17 | — | — | US | claimed |
| US-6429314-B1 | USING 1,2-DICARBONYL DERIVATIVE OR ITS HYDROXY REDUCTIVE, OXYGEN, COBALT ACETATE METAL COMPOUND, AND N-HYDROXYPHTHALIMIDE OR OTHER IMIDE DERIVATIVE | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2002-08-06 | — | — | US | claimed |
| US-5223765-A | DEVICE FOR THE DISPLAY OR PROJECTION OF IMAGES OR SIMILAR INFORMATION WITH COATING OF ADAMANTANE CARBON | THOMSON CONSUMER ELECTRONICS (FR) | 1993-06-29 | — | — | US | claimed |
| US-20250320193-A1 | OXOISOINDOLINYL SUBSTITUTED PIPERIDINEDIONE DERIVATIVE AND USE THEREOF | GLUETACS THERAPEUTICS (SHANGHAI) CO., LTD. (CN) | 2025-10-16 | — | — | US | disclosed |
| US-20250188100-A1 | SILA-ADAMANTANE STRUCTURES, DEVICES, AND METHODS | UNIV CALIFORNIA (US) | 2025-06-12 | — | — | US | disclosed |
| CN-118866159-A | Method for identifying high-polymer adamantane in crude oil by using molecular simulation technology | 长江大学 | 2024-10-29 | — | — | CN | disclosed |
| CN-117241920-A | Cutting element and hair removal device | GFD钻石制品有限公司 | 2023-12-15 | — | — | CN | disclosed |
| CN-117203027-A | Cutting element and hair removal device | GFD钻石制品有限公司 | 2023-12-08 | — | — | CN | disclosed |
| CN-117177849-A | Cutting element with asymmetric cutting segments | GFD钻石制品有限公司 | 2023-12-05 | — | — | CN | disclosed |
| WO-2023177686-A1 | SILA-ADAMANTANE STRUCTURES, DEVICES, AND METHODS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-09-21 | — | — | WO | disclosed |
| US-20090056802-A1 | Practical method and means for mechanosynthesis and assembly of precise nanostructures and materials including diamond, programmable systems for performing same; devices and systems produced thereby, and applications thereof | RABANI ELI MICHAEL | 2009-03-05 | — | — | US | disclosed |
| US-20080177094-A1 | 7-Ethynyl-2,4,9-Trithiaadamantane and Related Methods | AKRON, THE UNIVERSITY OF | 2008-07-24 | — | — | US | disclosed |
| US-20050253502-A1 | Optically enhanced nanomaterials | MATSUSHITA ELECTRIC WORKS, LTD. (JP) | 2005-11-17 | — | — | US | disclosed |
| WO-2005003089-A2 | 7-ETHYNYL-2,4,9-TRITHIAADAMANTANE AND RELATED METHODS | THE UNIVERSITY OF AKRON (US) | 2005-01-13 | — | — | WO | disclosed |
| US-5223765-A | DEVICE FOR THE DISPLAY OR PROJECTION OF IMAGES OR SIMILAR INFORMATION WITH COATING OF ADAMANTANE CARBON | THOMSON CONSUMER ELECTRONICS (FR) | 1993-06-29 | — | — | US | disclosed |
| US-5223765-A | DEVICE FOR THE DISPLAY OR PROJECTION OF IMAGES OR SIMILAR INFORMATION WITH COATING OF ADAMANTANE CARBON | THOMSON CONSUMER ELECTRONICS (FR) | 1993-06-29 | — | — | US | disclosed |
| US-5223765-A | DEVICE FOR THE DISPLAY OR PROJECTION OF IMAGES OR SIMILAR INFORMATION WITH COATING OF ADAMANTANE CARBON | THOMSON CONSUMER ELECTRONICS (FR) | 1993-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080177094-A1 | 7-Ethynyl-2,4,9-Trithiaadamantane and Related Methods | ALKBH2, TET1, AOX1 | CYP2C9 785/4885LMNA 4547/4885SLC22A2 2664/4885 |
| US-20250188100-A1 | SILA-ADAMANTANE STRUCTURES, DEVICES, AND METHODS | NAPA, ADAM8, TMEM63A | CYP2C9 2545/4885LMNA 652/4885SLC22A2 4233/4885 |
| US-20250320193-A1 | OXOISOINDOLINYL SUBSTITUTED PIPERIDINEDIONE DERIVATIVE AND USE THEREOF | CLN6, PSEN2, CRBN | CYP2C9 2614/4885LMNA 395/4885SLC22A2 1281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.